ArticlePreventing chronic disease2024
Chronic Disease Prevalence in the US: Sociodemographic and Geographic Variations by Zip Code Tabulation Area.
Article in Preventing chronic disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
75 citing papers in PubMed, 108 citations in OpenAlex.
- Genotype-Guided Antidepressant Prescribing for Patients With Depression: A Randomized Clinical Trial.JAMA network open · 2026Trial
- Baseline characteristics of survivors, primary care clinicians, and oncologists in a randomized trial of a shared care, self-management intervention for cancer survivors.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025Trial
- A brief, theory-driven patient education video reduces high-risk over-the-counter nonsteroidal anti-inflammatory drug (NSAID) use.PloS one · 2025Trial
- Transportation Walking Among US Adults With and Without Transportation Insecurity, 2022 National Health Interview Survey.Preventing chronic disease · 2026Article
- Access and Attrition Across Audiology and Cochlear Implant Care Among Older Adults with Bilateral Sensorineural Hearing Loss.Otology & neurotology open · 2026Article
- Associations of multiple evidence-based care strategies with disease mortality, life expectancy, and disparities in the United States.Health affairs scholar · 2026Article
- Age-Specific Risk of Herpes Zoster in Adults Aged ≥18 Years With Comorbid Conditions-A Retrospective Cohort Study in the United States.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026Article
- Social determinants of health across the lifecourse and chronic disease risk: available data and seminal findings from the Atherosclerosis Risk in Communities (ARIC) Study.American journal of epidemiology · 2026Review
- Syphilis-related mortality in the United States, 2021-2025: trends, demographic disparities, and clinical implications.BMC infectious diseases · 2026Article
- Postpandemic Telehealth Use: Patterns and Barriers for Older Adults in the United States, 2024.American journal of public health · 2026Article
- Person-Centered Care Planning: Palliative Symptom Management in Multiple Chronic Conditions.Learning health systems · 2026Article
- Call to Action: Antihunger and Public Health Communities Must Find Common Ground to Advance a More Just and Nutritious Food System in the United States.American journal of public health · 2026Article
- Contribution of fungal diseases to the U.S. chronic disease burden.Clinical microbiology reviews · 2026Review
- Healthcare expenditures associated with cardiovascular, chronic kidney, and diabetic conditions, 2021-2023.BMC nephrology · 2026Article
- User-Directed vs Interruptive Real-Time Benefit Tools for Medication Changes in Primary Care.JAMA network open · 2026Article
- Charleson and Elixhauser Comorbidity Indices in Predicting Mortality Among Young and Old Cervical Cancer Patients.Cancer medicine · 2026Article
- National mortality trends associated with the death certificate-reported co-occurrence of malignant neoplasms and bacterial diseases in the United States, 1999-2023: a CDC WONDER retrospective analysis.Annals of medicine and surgery (2012) · 2026Article
- Epidemiology of unspecified degenerative nervous system disorders: mortality trends via CDC WONDER (1999-2025).BMC neurology · 2026Article
- Beyond Rurality: Individual Socioeconomic Status and Chronic Disease Prevalence.medRxiv : the preprint server for health sciences · 2026Article
- The Electronic Medical Records and Genomics study: Design and analytic framework for assessing the impact of genome-informed risk assessments.American journal of human genetics · 2026Article
15 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 4 institutions in 1 country.
Funding
Abstract
Introduction: We examined the geographic distribution and sociodemographic and economic characteristics of chronic disease prevalence in the US. Understanding disease prevalence and its impact on communities is crucial for effective public health interventions. Methods: Data came from the American Community Survey, the American Hospital Association Survey, and the Centers for Disease Control and Prevention's PLACES. We used quartile thresholds for 10 chronic diseases to assess chronic disease prevalence by Zip Code Tabulation Areas (ZCTAs). ZCTAs were scored from 0 to 20 based on their chronic disease prevalence quartile. Three prevalence categories were established: least prevalent (score ≤6), moderately prevalent (score 7-13), and highest prevalence (score ≥14). Community characteristics were compared across categories and spatial analyses to identify clusters of ZCTAs with high disease prevalence. Results: Our study showed a high prevalence of chronic disease in the southeastern region of the US. Populations in ZCTAs with the highest prevalence showed significantly greater socioeconomic disadvantages (ie, lower household income, lower home value, lower educational attainment, and higher uninsured rates) and barriers to health care access (lower percentage of car ownership and longer travel distances to hospital-based intensive care units, emergency departments, federally qualified health centers, and pharmacies) compared with ZCTAs with the lowest prevalence. Conclusion: Socioeconomic disparities and health care access should be addressed in communities with high chronic disease prevalence. Carefully directed resource allocation and interventions are necessary to reduce the effects of chronic disease on these communities. Policy makers and clinicians should prioritize efforts to reduce chronic disease prevalence and improve the overall health and well-being of affected communities throughout the US.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.